Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$256,865,644
+$115,095,832 QoQ
Shares Held
2,033,130
+99.9% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#75
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$3,422
PutShares
12,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $3,273,366,479 across 12 Drug Manufacturers - General names. GILD ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,068,333 | $1,033,234,532 | |
| 2 | LLY |
ELI LILLY & Co
|
580,460 | $696,221,195 | |
| 3 | ABBV |
AbbVie Inc.
|
1,707,786 | $429,747,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,373,431 | $304,985,883 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
2,033,130 | $256,865,644 | |
| 6 | AZN |
Astrazeneca PLC
|
1,328,471 | $251,904,671 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,064,284 | $118,944,044 | |
| 8 | PFE |
Pfizer Inc
|
3,938,865 | $94,847,869 |
All Filings in GILD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,865,644 | 2,033,130 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $141,769,812 | 1,017,219 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $218,298,613 | 1,778,545 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $229,095,564 | 2,063,924 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $280,284,792 | 2,528,049 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $3,422 | 12,600 | Put | Sole | 2025-08-13 | |
| 2025-03-31 | $280,148,418 | 2,500,209 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $51,813,658 | 560,936 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $50,826,323 | 606,230 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $42,469,727 | 619,002 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $39,676,961 | 541,665 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $43,385,472 | 535,557 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $36,865,009 | 491,927 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $36,903,967 | 478,837 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $33,530,417 | 404,127 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $41,306,813 | 481,151 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $36,890,311 | 597,995 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $36,420,553 | 589,234 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $33,444,251 | 562,561 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $38,500,290 | 530,234 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $35,427,850 | 507,199 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $30,023,648 | 436,010 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $26,752,295 | 413,930 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,550,977 | 198,266 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $8,402,374 | 132,970 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,772,172 | 191,996 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $13,097,652 | 175,196 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||